Biodefense startup Valthos raises $30 million in funding, with participation from OpenAI
ChainCatcher news, biotechnology defense startup Valthos has raised $30 million in funding from the OpenAI Startup Fund, Lux Capital, and Founders Fund.
The company's AI system can update medical countermeasures according to the changing speed of biological threats, enabling researchers and government agencies to identify and respond to pathogens as quickly as possible. Valthos was founded in New York last November, and its leadership includes: former Palantir Technologies Head of Life Sciences Kathleen McMahon, former Oxford University computational neuroscience researcher Tess van Stekelenburg, and founding AI engineer Victor Mao (who previously served as a research engineer at Google DeepMind).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ampco-Pittsburgh Publishes Q3 2026 Earnings Call Transcript
Nvidia's newly appointed Chairman of the Board addresses all employees: The company's strength comes from its team, technology, and ecosystem.
In an email, NVIDIA's new Chairman of the Board Harvey Jones stated that the board takes its duty as guardian of this great company very seriously. The company's strength comes from our employees, leadership team, technological capabilities, and partner ecosystem. We will continue to drive business growth and lead the industry forward. Thank you all for your focus, professionalism, and dedication to NVIDIA.
Crypto prices
More
